Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#71 / 100 Total
LIPO - Lipella Pharmaceuticals Inc - Stock Price Chart
TickerLIPO [NASD]
CompanyLipella Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap5.80MEPS (ttm)-0.78
P/E-EPS this Y64.94%
Forward P/E-EPS next Y14.81%
PEG-EPS past 5Y-189.86%
P/S12.09EPS next 5Y-
P/B2.10EPS Q/Q12.10%
Dividend-Sales Q/Q23.58%
Insider Own51.01%Inst Own4.99%
Insider Trans1.70%Inst Trans-
Short Float0.86%Earnings-
Analyst Recom1.00Target Price2.00
Avg Volume62.23K52W Range0.64 - 2.71
Lipella Pharmaceuticals, Inc. develops and commercializes lipid-based therapies for common bladder syndromes. It offers LP-08 which consists of Sphingomyelin Phospholipid bilayers separated by aqueous compartments, LP-09, a liposomal formulation of Botulinum toxin, and LP-10, a proprietary liposomal formulation of Tacrolimus, a potent immunosuppressant and anti-inflammatory agent. The company was founded by Jonathan Kaufman and Michael Chancellor on February 15, 2005 and is headquartered in Pittsburgh, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kaufman Jonathan HSee remarks below.May 14 '24Buy0.7610,0007,590898,849May 15 04:39 PM
Kaufman Jonathan HSee remarks below.Mar 19 '24Buy0.8725,00021,802888,849Mar 19 06:21 PM
Kaufman Jonathan HSee remarks below.Mar 18 '24Buy0.7930,00023,649863,849Mar 19 06:21 PM
ZOM - Zomedica Corp - Stock Price Chart
TickerZOM [AMEX]
CompanyZomedica Corp
CountryUSA
IndustryMedical Devices
Market Cap180.60MEPS (ttm)-0.04
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y27.70%
P/S6.95EPS next 5Y-
P/B0.78EPS Q/Q-43.08%
Dividend-Sales Q/Q14.23%
Insider Own1.59%Inst Own8.60%
Insider Trans4.70%Inst Trans-2.90%
Short Float6.25%EarningsMay 09/a
Analyst Recom3.00Target Price0.44
Avg Volume5.96M52W Range0.12 - 0.25
Zomedica Corp. operates as a veterinary health company, which engages in the discovery, development, and commercialization of pharmaceuticals for the companion pet. It offers products for dogs and cats by focusing on the unmet needs of clinical veterinarians. Its TRUFORMA biosensor platform is designed to assist practitioners in the diagnosis of complex conditions. The company was founded by Gerald L. Solensky. on January 7, 2013 and is headquartered in Ann Arbor, MI.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
POWERS JOHNNY DDirectorMay 14 '24Buy0.1450,0006,9812,100,000May 15 04:30 PM
Blair Anthony KCOOMay 13 '24Buy0.14150,00021,000150,000May 14 04:31 PM
HEATON LARRY C IICEOMay 13 '24Buy0.14100,00014,200300,000May 13 05:07 PM
POWERS JOHNNY DDirectorMay 13 '24Buy0.14100,00014,0002,050,000May 14 04:31 PM
POWERS JOHNNY DDirectorDec 15 '23Buy0.17100,00016,5001,950Dec 18 09:20 AM
GHI - Greystone Housing Impact Investors LP - Stock Price Chart
TickerGHI [NYSE]
CompanyGreystone Housing Impact Investors LP
CountryUSA
IndustryMortgage Finance
Market Cap351.98MEPS (ttm)1.90
P/E8.05EPS this Y-10.68%
Forward P/E9.17EPS next Y-2.72%
PEG-EPS past 5Y3.67%
P/S2.88EPS next 5Y-
P/B1.05EPS Q/Q-28.13%
Dividend9.90%Sales Q/Q-40.19%
Insider Own1.71%Inst Own9.36%
Insider Trans1.29%Inst Trans1.97%
Short Float0.14%EarningsMay 08/b
Analyst Recom1.33Target Price18.64
Avg Volume42.43K52W Range14.44 - 17.40
Greystone Housing Impact Investors LP engages in the acquisition of a portfolio of mortgage revenue bonds that are issued by state and local housing authorities to provide construction and permanent financing for affordable multifamily and student housing and commercial properties. It operates through the following segments: Affordable Multifamily MRB Investment, Seniors and Skilled Nursing MRB Investments, MF Properties and Market-Rate Joint Venture Investments. The Affordable Multifamily MRB Investment segment consists of the Partnership's portfolio of MRBs, GILs and related property loans that have been issued to provide construction and/or permanent financing for multifamily residential and commercial properties in their market areas. The Seniors and Skilled Nursing MRB Investments segment consists of two MRBs and a property loan that have been issued to provide acquisition, construction and/or permanent financing for seniors housing and skilled nursing properties. The MF Properties segment consists primarily of student housing residential properties that were held by the Partnership. The Market-Rate Joint Venture Investments segment consists of the operations of ATAX Vantage Holdings, LLC, ATAX Freestone Holdings, LLC, ATAX Senior Housing Holdings I, LLC, and ATAX Great Hill Holdings LLC, which make noncontrolling investments in unconsolidated entities for the construction, stabilization, and ultimate sale of market-rate multifamily and seniors housing properties also includes the consolidated VIE of Vantage at San Marcos. The company was founded on April 2, 1998 and is headquartered in Omaha, NE.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Rogozinski KennethChief Executive OfficerMay 14 '24Buy15.473,60055,69257,164May 15 04:15 PM
Rogozinski KennethChief Executive OfficerMay 13 '24Buy15.564006,22453,564May 14 04:15 PM
Rogozinski KennethChief Executive OfficerMay 10 '24Buy15.671,00015,67053,164May 14 04:15 PM
Rogozinski KennethChief Executive OfficerAug 07 '23Buy15.922,00031,84051,519Aug 08 04:30 PM
LENZ - LENZ Therapeutics Inc. - Stock Price Chart
TickerLENZ [NASD, RUT]
CompanyLENZ Therapeutics Inc.
CountryUSA
IndustryBiotechnology
Market Cap422.01MEPS (ttm)-15.34
P/E-EPS this Y65.06%
Forward P/E-EPS next Y17.24%
PEG-EPS past 5Y-483.52%
P/S-EPS next 5Y25.90%
P/B0.75EPS Q/Q10.50%
Dividend-Sales Q/Q-
Insider Own30.15%Inst Own58.91%
Insider Trans15.49%Inst Trans-2.70%
Short Float2.65%EarningsMay 08/a
Analyst Recom1.00Target Price34.00
Avg Volume130.74K52W Range9.91 - 24.59
LENZ Therapeutics, Inc. operates as a clinical stage company, which develops ophthalmic pharmaceutical products. It offers eye drop product treatment for presbyopia. The company was founded by James McCollum in July 2013 and is headquartered in Del Mar, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Chevallard Daniel R.Chief Financial OfficerMay 14 '24Buy15.683,18849,9883,188May 15 04:13 PM
MCCOLLUM JAMES WDirectorMay 13 '24Buy15.9931,332501,093525,565May 14 05:29 PM
RA CAPITAL MANAGEMENT, L.P.DirectorMar 21 '24Buy15.03998,00915,000,0753,319,339Mar 25 08:48 PM
RRBI - Red River Bancshares Inc - Stock Price Chart
TickerRRBI [NASD, RUT]
CompanyRed River Bancshares Inc
CountryUSA
IndustryBanks - Regional
Market Cap331.06MEPS (ttm)4.68
P/E10.25EPS this Y-5.25%
Forward P/E9.75EPS next Y6.84%
PEG-EPS past 5Y8.99%
P/S2.27EPS next 5Y-
P/B1.10EPS Q/Q-13.12%
Dividend0.74%Sales Q/Q18.32%
Insider Own37.60%Inst Own22.04%
Insider Trans-0.15%Inst Trans-1.50%
Short Float0.50%EarningsApr 25/a
Analyst Recom1.00Target Price62.00
Avg Volume7.93K52W Range44.15 - 58.00
Red River Bancshares, Inc. is a bank holding company, which engages in the provision of banking products and services for commercial and retail customers through its subsidiary. It offers real estate and commercial loans, treasury management, retail banking networks, private banking, residential mortgage lending, and investment services. The company was founded on March 16, 1998 and is headquartered in Alexandria, LA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BROWN MICHAEL JDirectorMay 14 '24Buy47.772029,6502,103May 15 04:08 PM
BROWN MICHAEL JDirectorMay 13 '24Buy47.7540119,1471,901May 15 04:08 PM
Price Teddy RayDirectorMay 03 '24Buy47.0873834,742367,478May 03 02:22 PM
Price Teddy RayDirectorMay 03 '24Buy47.991316,28764,785May 03 02:22 PM
Salazar Tammi R.See RemarksMar 28 '24Sale50.0578139,08939,901Apr 01 02:50 PM
CFBK - CF Bankshares Inc - Stock Price Chart
TickerCFBK [NASD]
CompanyCF Bankshares Inc
CountryUSA
IndustryBanks - Regional
Market Cap122.91MEPS (ttm)2.41
P/E7.79EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y21.36%
P/S1.05EPS next 5Y-
P/B0.60EPS Q/Q-30.29%
Dividend1.28%Sales Q/Q20.93%
Insider Own43.73%Inst Own21.19%
Insider Trans0.20%Inst Trans-1.34%
Short Float0.10%EarningsMay 07/b
Analyst Recom3.00Target Price18.00
Avg Volume5.78K52W Range14.69 - 22.00
CF Bankshares, Inc. operates as a financial holding company which is engaged in the provision of business banking products and services. Its products and services include commercial loans and leases, commercial and residential real estate loans and treasury management depository services. The company was founded in September 1998 and is headquartered in Columbus, OH.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ASH THOMAS PDirectorMay 15 '24Buy18.965009,47843,119May 15 03:50 PM
O'Dell Timothy TCEOMay 14 '24Buy18.9596018,192296,588May 15 04:07 PM
O'Dell Timothy TCEOMay 13 '24Buy18.891,33325,186297,921May 15 04:07 PM
Royer David LDirectorNov 29 '23Buy16.002,50040,00030,012Nov 30 04:16 PM
ASH THOMAS PDirectorNov 22 '23Buy17.505008,75039,444Nov 27 02:45 PM
ZLAB - Zai Lab Limited ADR - Stock Price Chart
TickerZLAB [NASD]
CompanyZai Lab Limited ADR
CountryChina
IndustryBiotechnology
Market Cap1.97BEPS (ttm)-3.50
P/E-EPS this Y13.82%
Forward P/E-EPS next Y55.97%
PEG-EPS past 5Y-16.93%
P/S6.76EPS next 5Y-
P/B2.55EPS Q/Q-7.51%
Dividend-Sales Q/Q38.78%
Insider Own0.54%Inst Own42.51%
Insider Trans-11.16%Inst Trans-1.97%
Short Float4.44%EarningsMay 08/a
Analyst Recom1.15Target Price51.82
Avg Volume640.61K52W Range13.48 - 37.92
Zai Lab Ltd. is a biopharmaceutical company, which engages in the developing and commercializing therapies that address medical conditions with unmet needs in oncology, autoimmune disorders, infectious diseases, and neuroscience. Its products include Zejula, Optune, Qinlock, and Nuzyra. The company was founded by Samantha Ying Du and Marietta Wu in April 2014 and is headquartered in Shanghai, China.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Edmondson Frazor Titus IIIChief Legal OfficerMay 14 '24Sale21.3310,000213,34616,408May 16 04:52 PM
Smiley Joshua LSee RemarksMay 13 '24Buy21.403,00064,20031,684May 15 04:03 PM
Reinhart HaraldSee RemarksApr 04 '24Sale15.672,10532,99251,800Apr 05 05:48 PM
Smiley Joshua LSee RemarksApr 04 '24Sale15.671,98831,15828,684Apr 05 05:48 PM
Amado RafaelSee RemarksApr 04 '24Sale15.671,95230,59423,532Apr 05 05:47 PM
GBLI - Global Indemnity Group LLC - Stock Price Chart
TickerGBLI [NYSE]
CompanyGlobal Indemnity Group LLC
CountryUSA
IndustryInsurance - Property & Casualty
Market Cap429.22MEPS (ttm)2.47
P/E12.77EPS this Y28.83%
Forward P/E10.29EPS next Y21.47%
PEG1.28EPS past 5Y-
P/S0.88EPS next 5Y10.00%
P/B0.66EPS Q/Q380.37%
Dividend4.44%Sales Q/Q-25.59%
Insider Own50.07%Inst Own38.62%
Insider Trans0.12%Inst Trans-1.05%
Short Float0.11%EarningsMay 08/b
Analyst Recom3.00Target Price55.00
Avg Volume5.36K52W Range25.21 - 37.00
Global Indemnity Group LLC engages in providing diversified insurance and reinsurance services. It operates through the following segments: Commercial Specialty, Reinsurance Operations, and Exited Lines. The Commercial Specialty segment provides specialty and casualty products designed for product lines such as small business binding authority, property brokerage, vacant express and programs. The Specialty Property segment offers specialty personal lines property and casualty insurance products. The Reinsurance Operations segment provides reinsurance solutions through brokers and primary writers including insurance and reinsurance companies. The company was founded in 2003 and is headquartered in Bala Cynwyd, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BROWN JOSEPH WChief ExecutiveMay 13 '24Buy32.478,000259,745155,404May 15 04:02 PM
AAOI - Applied Optoelectronics Inc - Stock Price Chart
TickerAAOI [NASD]
CompanyApplied Optoelectronics Inc
CountryUSA
IndustryCommunication Equipment
Market Cap436.96MEPS (ttm)-1.83
P/E-EPS this Y1.79%
Forward P/E14.34EPS next Y289.90%
PEG-EPS past 5Y-74.26%
P/S2.13EPS next 5Y13.00%
P/B2.22EPS Q/Q-7.04%
Dividend-Sales Q/Q-23.30%
Insider Own7.72%Inst Own77.29%
Insider Trans0.27%Inst Trans-2.47%
Short Float24.58%EarningsMay 09/a
Analyst Recom2.00Target Price15.33
Avg Volume2.54M52W Range1.65 - 24.75
Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Yeh William HDirectorMay 14 '24Buy10.549,800103,292217,055May 15 04:02 PM
Lin Che-WeiDirectorMar 18 '24Buy12.7031,370398,283220,133Mar 18 04:05 PM
Lin Chih-Hsiang (Thompson)President and CEOMar 18 '24Buy12.6611,780149,1691,218,160Mar 18 04:04 PM
Yeh William HDirectorMar 18 '24Buy12.758,000102,000207,255Mar 19 04:20 PM
Yeh William HDirectorFeb 27 '24Buy15.2910,000152,900199,255Feb 28 04:02 PM
WBD - Warner Bros. Discovery Inc - Stock Price Chart
TickerWBD [NASD, NDX, S&P 500]
CompanyWarner Bros. Discovery Inc
CountryUSA
IndustryEntertainment
Market Cap20.17BEPS (ttm)-1.24
P/E-EPS this Y48.73%
Forward P/E79.56EPS next Y115.76%
PEG-EPS past 5Y-
P/S0.50EPS next 5Y-
P/B0.46EPS Q/Q9.69%
Dividend-Sales Q/Q-6.96%
Insider Own9.54%Inst Own62.22%
Insider Trans0.04%Inst Trans-0.00%
Short Float4.79%EarningsMay 09/b
Analyst Recom2.14Target Price12.11
Avg Volume31.69M52W Range7.34 - 14.76
Warner Bros. Discovery, Inc. is a premier global media and entertainment company, which engages in the provision of a differentiated portfolio of content, brands, and franchises across television, film, streaming, and gaming. It operates through the following segments: Studios, Networks, Direct-to-Consumer (DTC), and Corporate. The Studios segment includes producing and releasing feature films for initial exhibition in theaters, producing and initial licensing television programs to networks services as well as third parties, distributing films and television programs to various third party, internal television, and streaming services, distribution through the home entertainment market related consumer products, and themed experience licensing and interactive gaming. The Networks segment focuses on domestic and international television networks. The DTC segment is involved in premium pay-television and streaming services. The company was founded on June 17, 1985 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Zeiler GerhardPresident, InternationalMay 13 '24Buy8.30100,000830,000908,130May 15 04:02 PM
ADVANCE/NEWHOUSE PARTNERSHIPDirectorDec 14 '23Buy12.4910,000,000124,900,00014,158,459Dec 15 06:52 PM
Newhouse Steven ODirectorDec 14 '23Buy12.4910,000,000124,900,00014,158,459Dec 15 06:54 PM
Newhouse Steven ODirectorDec 14 '23Sale12.4910,000,000124,900,000184,023,290Dec 15 06:54 PM
ADVANCE/NEWHOUSE PROGRAMMING PDirectorDec 14 '23Sale12.4910,000,000124,900,000184,023,290Dec 15 06:56 PM
12345678910